Top Markets
#1 Pleasing Gold Pleasing Gold +1,463.64%
#2 PulseChain PulseChain +59.45%
#3 BOOK OF MEME BOOK OF MEME +34.33%
#4 Merlin's Seal BTC Merlin's Seal BTC +32.88%
#5 Ontology Gas Ontology Gas +28.49%
#6 Unit Pump Unit Pump +24.72%
#7 Pump.fun Pump.fun +24.72%
#8 Nockchain Nockchain +22.61%
#9 Neiro Neiro +21.92%
#10 ConstitutionDAO ConstitutionDAO +20.25%
Coin of the day
Pleasing Gold Pleasing Gold
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
Chordia Therapeutics Inc. Chordia Therapeutics Inc.

Chordia Therapeutics Inc.

190A
Classement en actions #26480
Chordia Therapeutics Inc., a biotech company, engages in research and... Chordia Therapeutics Inc., a biotech company, engages in research and development of anti-cancer drugs that targets RNA deregulation stress in Japan. It develops CLK CTX-712, a CLK inhibitor, which is Phase 1 clinical trial for the treatment of relapsed or refractory malignant cancers.; CTX-177, a small-molecule inhibitor of MALT1; CDK12 inhibitor CTX-439; and GCN2 inhibitor CRD-1968099. Chordia Therapeutics Inc. was incorporated in 2017 and is based in Fujisawa, Japan.
Prix de l'action
$0.53499835
Capitalisation boursière
$40.24M
Changement (1 jour)
2.50%
Changement (1 an)
-58.07%
Pays
JP
Échange Chordia Therapeutics Inc. (190A)

Catégorie

Healthcare
Historique du prix de l'action pour Chordia Therapeutics Inc. (190A)
Prix de clôture le plus élevé : $0.53 le 2026-08-01

Prix de clôture le plus bas : $1.06 le 2024-06-01
Historique du prix de l'action de Chordia Therapeutics Inc. de 2024 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) 10.93%
2025 -61.05%
2024 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $546.54 38.59%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.04K 56.71%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $120.74 -14.98%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $138.98 416.85%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $761.87 7.04%
CH